Medical Malpractice Screening Panels by State

Medical malpractice screening panels are pre-litigation mechanisms established by state statute that require certain malpractice claims to be reviewed by a neutral body before a lawsuit may proceed to civil court. This page covers how these panels are defined under state law, how the review process operates procedurally, the claim types and settings where panels most commonly apply, and the legal boundaries that determine when panel decisions are binding versus advisory. Understanding screening panels is essential context for anyone analyzing the elements of a medical malpractice claim or the broader medical malpractice complaint filing process.

Definition and Scope

A medical malpractice screening panel — also called a pre-litigation panel, medical review panel, or tribunal — is a quasi-judicial body created by state legislation to evaluate whether a malpractice claim has sufficient merit to warrant full civil litigation. Panels exist as a mechanism of medical malpractice tort reform, designed to filter out claims lacking evidentiary support before they consume court resources or impose defense costs on healthcare providers.

State adoption of screening panels is neither uniform nor universal. As of the most recently compiled legislative surveys by the National Conference of State Legislatures (NCSL), roughly 15 to 20 states maintain some form of mandatory or optional pre-litigation review panel, though statutory designs vary significantly. States including Indiana, Louisiana, and Maine operate compulsory medical review panel systems with detailed enabling statutes, while states such as Hawaii and Utah have enacted voluntary or arbitration-adjacent processes. Several states that once had screening panel laws — including Idaho and New Hampshire — repealed or modified those statutes after courts found constitutional deficiencies.

Panel composition typically draws from three categories of participants:
1. A licensed physician in the relevant specialty
2. A licensed attorney (often one plaintiff-side and one defense-side representative)
3. A neutral layperson or presiding judge

Indiana's Medical Malpractice Act (Indiana Code § 34-18), one of the most frequently cited state models, requires that claims against qualified healthcare providers pass through a three-physician panel review before a complaint may be filed in state court.

How It Works

The procedural structure of a screening panel follows a recognizable sequence across most states, though individual steps vary by enabling statute:

  1. Claim submission — A claimant files a proposed complaint and supporting documentation (typically including medical records) with the designated panel authority, which is often a state insurance commissioner's office or a specialized medical review board.
  2. Provider response — The named healthcare provider submits a written response, frequently accompanied by expert declarations or clinical documentation.
  3. Expert selection — Panelists with relevant clinical expertise are appointed or selected through a process defined by statute. Expert selection rules intersect with the standards covered in expert witness requirements for medical malpractice claims.
  4. Document review or hearing — Depending on jurisdiction, panels conduct either a paper review of submitted materials or hold an evidentiary hearing at which both parties may present arguments.
  5. Panel opinion — The panel issues a written opinion stating whether the evidence supports a conclusion that the provider breached the applicable standard of care.
  6. Admissibility determination — The panel's opinion may be admissible as evidence at any subsequent civil trial, depending on whether the jurisdiction treats the opinion as binding, presumptive, or purely advisory.

The statute of limitations is typically tolled — suspended — during the pendency of the panel review. Indiana Code § 34-18-7-3 explicitly provides that the limitations period does not run while a proposed complaint is pending before the panel, a safeguard also relevant to medical malpractice statute of limitations analysis.

Common Scenarios

Screening panels most commonly arise in four distinct factual contexts:

Surgical and procedural claims — Claims arising from intraoperative errors, wrong-site procedures, or retained foreign objects are frequently routed through panels in mandatory-review states. These align with the claim types analyzed under surgical malpractice legal standards.

Diagnostic failure claims — Panels in states like Louisiana regularly address misdiagnosis and failure-to-diagnose claims, where the causal link between delayed diagnosis and patient harm requires expert clinical analysis before litigation becomes appropriate.

Birth injury claims — Given the complex causation questions in perinatal injury matters, screening panels in several states are frequently invoked in birth injury malpractice cases. The Virginia Birth-Related Neurological Injury Compensation Program (NICA) operates as a separate no-fault compensation mechanism, distinct from a standard screening panel but serving an analogous gatekeeping function.

Hospital and institutional claims — Where claims target hospitals or healthcare systems through vicarious liability theories, institutional defendants in panel states must typically participate in the review process alongside named individual providers.

Decision Boundaries

The legal effect of a panel's opinion — and therefore its strategic importance — turns on four key variables:

Binding vs. advisory opinions — Louisiana's Medical Malpractice Act (Louisiana Revised Statutes § 40:1231.8) produces panel opinions that are admissible at trial but not conclusively binding; either party may reject the panel's finding and proceed to court. Indiana's system similarly produces opinions that are admissible but not dispositive. By contrast, some earlier-generation tribunal statutes (Massachusetts abolished its tribunal system in 2012 after decades of constitutional litigation) conditioned the plaintiff's right to proceed on posting a bond upon an adverse tribunal finding.

Constitutional limits — State courts have invalidated screening panel statutes on due process, equal protection, and right-to-jury-trial grounds. The Tennessee Supreme Court's 1994 decision in Constitutionality of the Tennessee Medical Malpractice Review Board and similar rulings in other jurisdictions establish that mandatory panel review must not function as an effective bar to court access.

Interaction with pre-suit notice — In jurisdictions requiring both a screening panel and a formal pre-suit notice, the claimant must satisfy both procedural requirements sequentially. Failure to complete panel review before filing a civil complaint results in dismissal in mandatory-panel states.

Damage cap applicability — In Indiana, only providers who qualify under the Medical Malpractice Act — and therefore are subject to panel review — benefit from the Act's damage caps (Indiana Code § 34-18-14-3), currently set at $1.8 million per occurrence. Non-qualified providers face no cap but also face no panel requirement. This linkage between panel participation and damage caps by state is a structural feature, not an anomaly.

Tolling scope — Panels toll the statute of limitations only while a properly filed proposed complaint is pending. Defective submissions, withdrawn claims, or panels convened outside the statutory process may not trigger tolling, creating a trap for claimants who assume the panel process automatically preserves their claim window.

References

📜 8 regulatory citations referenced  ·  🔍 Monitored by ANA Regulatory Watch  ·  View update log

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Attorney Fee Estimator